GLS and breast cancer: Significantly, the analysis of online data revealed that patients with colorectal and breast cancer who exhibited high expression of GLS1 experienced a shorter duration of Distant Metastasis Free Survival (DMFS) compared to those with low expression, which suggests that GLS1 plays a crucial role in influencing the prognosis of colorectal and breast cancer patients (Figure 10E,F).